Bansag, Jumar A.

HRN: 23-95-50  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/26/2023
11/01/2023
IV
135mg
Q8h
Acute Gastroenteritis
Waiting Final Action 
10/28/2023
CEFUROXIME 1.5GM (VIAL)
10/28/2023
11/04/2023
IVTT
450mg
Q8
T/C UTI
Waiting Final Action 
11/02/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/02/2023
11/05/2023
PO
5.5ml
Q8hours
Acute Gastroenteritis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: